Let’s start up with the current stock price of Bionano Genomics Inc. (BNGO), which is $1.89 to be very precise. The Stock rose vividly during the last session to $1.83 after opening rate of $1.75 while the lowest price it went was recorded $1.70 before closing at $1.83.Recently in News on January 23, 2023, Bionano Announces Launch of Next-Generation Versions of its Reagent Kits and Chip Consumable, Along with Updates to its Instrument Control and Bionano Access Software for the Optical Genome Mapping Workflow. Bionano Prep SP-G2 (SP-G2) kit offers higher gDNA quality, improved ease-of-use and increased DNA throughput. You can read further details here
Bionano Genomics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.9800 on 01/18/23, with the lowest value was $1.3700 for the same time period, recorded on 01/06/23.
Bionano Genomics Inc. (BNGO) full year performance was -21.12%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Bionano Genomics Inc. shares are logging -56.44% during the 52-week period from high price, and 63.36% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.16 and $4.35.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3939962 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Bionano Genomics Inc. (BNGO) recorded performance in the market was 25.34%, having the revenues showcasing -6.63% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 504.81M, as it employees total of 299 workers.
Analysts verdict on Bionano Genomics Inc. (BNGO)
During the last month, 0 analysts gave the Bionano Genomics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.0620, with a change in the price was noted -0.55. In a similar fashion, Bionano Genomics Inc. posted a movement of -22.59% for the period of last 100 days, recording 6,852,827 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BNGO is recording 0.01 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.01.
Bionano Genomics Inc. (BNGO): Technical Analysis
Raw Stochastic average of Bionano Genomics Inc. in the period of last 50 days is set at 31.61%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 84.55%. In the last 20 days, the company’s Stochastic %K was 71.54% and its Stochastic %D was recorded 72.08%.
Let’s take a glance in the erstwhile performances of Bionano Genomics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 25.34%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -6.15%, alongside a downfall of -21.12% for the period of the last 12 months. The shares increased approximately by 0.55% in the 7-day charts and went down by 10.91% in the period of the last 30 days. Common stock shares were lifted by -6.63% during last recorded quarter.